Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.690
+0.330 (24.26%)
At close: Jun 6, 2025, 4:00 PM
1.680
-0.010 (-0.59%)
After-hours: Jun 6, 2025, 7:55 PM EDT

Prime Medicine Stock Forecast

PRME's stock price has decreased by -74.32% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for Prime Medicine stock ranges from a low of $1.50 to a high of $18. The average analyst price target of $9.38 forecasts a 455.03% increase in the stock price over the next year.

Price Target: $9.38 (+455.03%)
Analyst Consensus: Buy
Target Low Average Median High
Price $1.50 $9.38 $12 $18
Change -11.24% +455.03% +610.06% +965.09%

Analyst Ratings

The average analyst rating for Prime Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Dec '24Jan '25Feb '25Mar '25Apr '25May '25
Strong Buy 666662
Buy 333331
Hold 000003
Sell 000000
Strong Sell 000000
Total 999996

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Hold
Downgrades
$10$1.5
Hold Downgrades $10$1.5 -11.24% May 27, 2025
JMP Securities
JMP Securities
Buy
Maintains
$10$6
Buy Maintains $10$6 +255.03% May 20, 2025
JP Morgan
JP Morgan
Hold
Downgrades
n/a
Hold Downgrades n/a n/a May 20, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a May 20, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$16$12
Strong Buy Maintains $16$12 +610.06% May 19, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
6.09M
from 2.98M
Increased by 104.12%
Revenue Next Year
18.07M
from 6.09M
Increased by 196.78%
EPS This Year
-1.33
from -1.65
EPS Next Year
-1.17
from -1.33
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
5.21M---2.98M6.09M18.07M30.54M
Revenue Growth
-----104.12%196.78%68.99%
EPS
-1.91-14.19-4.19-2.18-1.65-1.33-1.17-1.07
EPS Growth
--------
Forward PE
--------
No. Analysts
-----151413
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 18.9M 84.0M 141.8M
Avg 6.1M 18.1M 30.5M
Low 1.4M n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
533.6%
1,279.5%
684.4%
Avg
104.1%
196.8%
69.0%
Low
-52.4%
- -

EPS Forecast

EPS 20252026202720282029
High -0.99 -0.64 -0.48
Avg -1.33 -1.17 -1.07
Low -1.57 -1.57 -1.62

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.